These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 30068533)

  • 1. Depressed Gamma Interferon Responses and Treatment Outcomes in Tuberculosis Patients: a Prospective Cohort Study.
    Feng JY; Pan SW; Huang SF; Chen YY; Lin YY; Su WJ
    J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30068533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of interferon-gamma response to mitogen in serial QuantiFERON-TB Gold In-Tube assay of routine laboratory practice.
    Woo KS; Choi JL; Kim BR; Kim JE; Kim BG; Lee H; Kim KH
    Clin Chim Acta; 2014 Mar; 430():79-83. PubMed ID: 24389051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy.
    Kabeer BS; Raja A; Raman B; Thangaraj S; Leportier M; Ippolito G; Girardi E; Lagrange PH; Goletti D
    BMC Infect Dis; 2011 May; 11():135. PubMed ID: 21595874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative Analysis of Gamma Interferon Release Assay Response in Children with Latent and Active Tuberculosis.
    Lombardi G; Petrucci R; Corsini I; Bacchi Reggiani ML; Visciotti F; Bernardi F; Landini MP; Cazzato S; Dal Monte P
    J Clin Microbiol; 2018 Feb; 56(2):. PubMed ID: 29142046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of tuberculosis treatment and antiretroviral therapy on serial RD-1-specific quantitative T-cell readouts (QuantiFERON-TB Gold In-Tube), and relationship to treatment-related outcomes and bacterial burden.
    Mthiyane T; Rustomjee R; Pym A; Connolly C; Onyebujoh P; Theron G; Dheda K
    Int J Infect Dis; 2015 Jul; 36():46-53. PubMed ID: 26003404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube Interferon Gamma Release Assays in Patients at Risk for Tuberculosis and in Health Care Workers.
    Theel ES; Hilgart H; Breen-Lyles M; McCoy K; Flury R; Breeher LE; Wilson J; Sia IG; Whitaker JA; Clain J; Aksamit TR; Escalante P
    J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29743310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of IFN-γ responses in IGRA among pulmonary TB suspects in a TB-endemic area.
    Feng JY; Huang SF; Lee MC; Ting WY; Chen YC; Lin YY; Lee YC; Su WJ
    Diagn Microbiol Infect Dis; 2013 Sep; 77(1):46-52. PubMed ID: 23867329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro QuantiFERON-TB gold antigen specific interleukin-1beta to diagnose TB among HIV-positive subjects.
    Prabhavathi M; Ahamed Kabeer BS; Deenadayalan A; Raja A
    Tuberculosis (Edinb); 2016 Jan; 96():27-30. PubMed ID: 26786651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transitional changes in T-cell responses to Mycobacterium tuberculosis-specific antigens during treatment.
    Kobashi Y; Mouri K; Yagi S; Obase Y; Miyashita N; Oka M
    J Infect; 2009 Mar; 58(3):197-204. PubMed ID: 18848730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of whole-blood interferon-γ and flow cytometry assays for detecting post-treatment immune responses in patients with active tuberculosis.
    Kim CH; Choi KJ; Yoo SS; Lee SY; Won DI; Lim JO; Cha SI; Park JY; Lee J
    Cytometry B Clin Cytom; 2014 Jul; 86(4):236-43. PubMed ID: 23959689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-γ release assay in HIV-infected patients with active tuberculosis: impact of antituberculous drugs on host immune response.
    Sauzullo I; Mengoni F; Ermocida A; Massetti AP; D'Agostino C; Russo G; Salotti A; Falciano M; Vullo V; Mastroianni CM
    New Microbiol; 2014 Apr; 37(2):153-61. PubMed ID: 24858642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of Mycobacterium tuberculosis-specific IFN-γ responses and sputum bacillary clearance in HIV-infected adults during treatment of pulmonary tuberculosis.
    Mzinza DT; Sloan DJ; Jambo KC; Shani D; Kamdolozi M; Wilkinson KA; Wilkinson RJ; Davies GR; Heyderman RS; Mwandumba HC
    Tuberculosis (Edinb); 2015 Jul; 95(4):463-9. PubMed ID: 26051653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Accuracy of Early Secretory Antigenic Target-6-Free Interferon-gamma Release Assay Compared to QuantiFERON-TB Gold In-tube.
    Nemes E; Abrahams D; Scriba TJ; Ratangee F; Keyser A; Makhethe L; Erasmus M; Mabwe S; Bilek N; Rozot V; Geldenhuys H; Hatherill M; Lempicki MD; Holm LL; Bogardus L; Ginsberg AM; Blauenfeldt T; Smith B; Ellis RD; Loxton AG; Walzl G; Andersen P; Ruhwald M
    Clin Infect Dis; 2019 Oct; 69(10):1724-1730. PubMed ID: 30668657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of the mitogen response in the interferon-γ release assay in patients with culture-confirmed tuberculosis.
    Huang CT; Lee MR; Ruan SY; Tsai YJ; Wang JY; Yu CJ
    Respir Med; 2019; 158():49-54. PubMed ID: 31605921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrimination between active and latent tuberculosis based on ratio of antigen-specific to mitogen-induced IP-10 production.
    Jeong YH; Hur YG; Lee H; Kim S; Cho JE; Chang J; Shin SJ; Lee H; Kang YA; Cho SN; Ha SJ
    J Clin Microbiol; 2015 Feb; 53(2):504-10. PubMed ID: 25428147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon gamma release assays for monitoring the response to treatment for tuberculosis: A systematic review.
    Clifford V; He Y; Zufferey C; Connell T; Curtis N
    Tuberculosis (Edinb); 2015 Dec; 95(6):639-650. PubMed ID: 26515270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventive tuberculosis treatment effect on QuantiFERON TB-Gold in-tube testing in a high tuberculosis-endemic country: A clinical trial.
    Yang Q; Ruan Q; Liu X; Shen Y; Jiang T; Wu J; Cai L; Pan K; Lin M; Huang X; Shao L; Zhang W
    Int J Infect Dis; 2020 Feb; 91():182-187. PubMed ID: 31770617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of immune parameters during the treatment of active tuberculosis showing negative interferon gamma response at the time of diagnosis.
    Matsushita I; Hang NT; Hong le T; Tam do B; Lien LT; Thuong PH; Cuong VC; Hijikata M; Kobayashi N; Sakurada S; Higuchi K; Harada N; Keicho N
    Int J Infect Dis; 2015 Nov; 40():39-44. PubMed ID: 26439971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of rituximab therapy on released interferon-γ levels in the QuantiFERON assay among RA patients with different status of Mycobacterium tuberculosis infection.
    Chen YM; Chen HH; Lai KL; Hung WT; Lan JL; Chen DY
    Rheumatology (Oxford); 2013 Apr; 52(4):697-704. PubMed ID: 23264552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.